1. Huge Win for Cancer Research

    Congress has approved a $2 billion increase in funding for the National Institutes of Health. The 6.6 percent hike -- to $32.1 billion -- is the largest increase in 12 years and it will make an enormous difference in supporting cancer research in the years ahead. The bill includes a $264 million increase in funding for the National Cancer Institute (boosting NCI funding for the year to $5.2 billion – a 5.3% increase) as well as $200 million in funding for a precision medicine initiative ...

    Read More
  2. Looking Ahead to 2016

    LLS CEO and President Louis J. DeGennaro speaks out about coming off a “phenomenal” year and what we can look forward to in 2016. He shares his optimism about a future with no chemotherapy, the use of the word “cure,” the increasing promise of immunotherapy, and the potential of having hundreds of compounds in development. Six top topics that will be important for blood cancer patients and families: Precision Medicine. We’re continuing the track toward precision medicine, w...

    Read More
  3. Surviving Leukemia: Now My Brother Lives Inside of Me

    Well, times were dark indeed Feeling my body betrayed me Life was good. My wife Bonnie and I were settling into a lifestyle that was becoming less demanding and more fun. Our only son was about to graduate college. My son and I were making music together and playing some local clubs and bars. I was physically active and worked out regularly. I had recently made changes to my diet due to a history of slightly high cholesterol and was curious to see what effect (if any) it would have...

    Read More
  4. Finding a New Normal

    So you’re in remission and you can officially call yourself a cancer survivor. Congratulations for making it through the hardest part of the journey. Now you may be thinking “What comes next?” Most people don’t think about survivorship until they finish treatment. And it’s only much later, when there hasn’t been a recurrence and they’re not thinking about the cancer so much, that they really contemplate long-term survival. At that point, there can be many questions: What can ...

    Read More
  5. #ASH15 Day 4: Breakthrough Therapy Designation for Novel Immunotherapy

    Yesterday we learned the exciting news that the FDA has granted Breakthrough Therapy designation for an investigational immunotherapy LLS is supporting through our Therapy Acceleration Program (TAP). The therapy, KTE-C19, being developed by Kite Pharma, is another example of a chimeric antigen receptor (CAR), an approach that genetically engineers patients’ immune T cells and reintroduces them into the body to kill cancer cells. KTE-C19 is crafted by removing patients' T cells and geneti...

    Read More
  6. The First Official Day of #ASH15

    Beat AML is a collaboration launched nearly three years ago by LLS and the Knight Cancer Institute at Oregon Health & Science University (OHSU), to go on the offenensive against acute myeloid leukemia (AML), a blood cancer with a poor prognosis and little change in the standard of care in 40 years. More than a dozen abstracts from the first phase of the initiative will be featured throughout the American Society of Hematology (#ASH15) Annual Meeting in Orlando over the next few days. #...

    Read More
  7. Do I Have Cancer? I Almost Forgot

    When I was first admitted to the hospital, a nurse told me that I was lucky to have my kind of cancer. Half of me said “Screw you!” and the other half said, “You’re right.” Today, I am nearing the 2 ½ year anniversary of my chronic myelogenous leukemia (CML) diagnosis. My blood is in remission from the disease, and my bone marrow is almost there, too. Cancer feels very far away from my daily life—when I take my pills, I don’t think “Ho hum, taking my oral chemotherapy!”. Th...

    Read More
  8. Surviving AML: The Long Road Back

    “Hola,” I said playfully, as I answered my cell phone on a beautiful Saturday -- April 21, 2012. “This is Dr. so and so. I’m calling because your blood work from yesterday is all out of whack.” “What do you mean, ‘Out of whack?’” “Your white blood cell count is high,” he said. “What’s high? “It's at 63,000.” “And what's it supposed to be?” “10,000.” In that moment, while at a barbecue with friends, I knew that I had leukemia. I uncharacteristica...

    Read More
  9. Balancing Expenses of Cancer Care: Turning Monetary Woes into Financial Feats

    I would never have imagined that at the age of 29, I would be lying in intensive care fighting for my life with stage IV anaplastic large cell lymphoma (ALCL). What a wake-up call, literally! Nicknamed “Sleeping Beauty,” I woke up after three weeks to learn my true diagnosis following months of illness. By the time I opened my eyes, I had already undergone my first five-day round of chemotherapy…with five more sessions to go. It was going to be a long summer. But as it turns out, ...

    Read More
  10. LLS Activates to Accelerate Cures

    The Leukemia & Lymphoma Society (LLS) continually advocates for laws and policies to ensure that patients have access to lifesaving treatments. Our latest win came this summer when the U.S. House of Representatives approved the 21st Century Cures Act. This bill, which is proof of LLS’s impact and would make a big difference for blood cancer patients, is now on Congress’ “to do” list. The House of Representatives finished its work on the 21st Century Cures Act in July, levera...

    Read More